Smoking prevalence, cigarette consumption and advice received from physicians: Change between 1996 and 2006 in Geneva, Switzerland

Addictive Behaviors
J F Etter

Abstract

To assess change between 1996 and 2006 in smoking prevalence, cigarette consumption, quit attempts, motivation to quit and advice received from physicians in Geneva, Switzerland. Postal surveys in cross-sectional, representative samples of the general population of Geneva in 1996 and 2006. There were 742 participants in 1996 (response rate 75%) and 1487 in 2006 (response rate 76%). Smoking prevalence remained stable between 1996 (28.0%, 95% confidence interval: 24.7 to 31.3%) and 2006 (26.5%, 24.3 to 28.7%, p=0.46). Among smokers, cigarette consumption fell from 15 to 13 cig./day between 1996 and 2006 (p=0.003). However, tobacco dependence, as measured by the Heaviness of Smoking Index, remained stable (mean=1.9 vs. 1.7, p=0.18). The proportion of smokers who made a 24-hour quit attempt in the previous year remained stable (29.2% in 1996, 32.1% in 2006, p=0.52), but more smokers reported that they intended to quit in the next 6 months in 2006 (39.6%) than in 1996 (29.1%, p=0.045). The association between smoking prevalence and income was stronger in 2006 (chi(2)=53.7, p<0.001) than in 1996 (chi(2)=10.9, p=0.012). In 2006 (no change since 1996), few smokers reported that, during their last medical visit, their physician told the...Continue Reading

References

Nov 22, 1997·Journal of Clinical Epidemiology·J F Etter, T V Perneger
Nov 22, 1997·Journal of Clinical Epidemiology·D A AschN A Christakis
Feb 26, 1998·American Journal of Preventive Medicine·J P Humair, J Ward
Jan 5, 2002·American Journal of Public Health·Alfredo MorabiaJean-Charles Rielle
Jun 24, 2004·BMJ : British Medical Journal·Richard DollIsabelle Sutherland
Sep 17, 2004·Addiction·Jean-François Etter
Jun 17, 2006·American Journal of Preventive Medicine·Michael V MaciosekLeif I Solberg
Jun 17, 2006·American Journal of Preventive Medicine·Leif I SolbergMichael J Goodman
Jul 12, 2008·American Journal of Preventive Medicine·UNKNOWN Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff

❮ Previous
Next ❯

Citations

Jan 26, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Jean-François Etter, Gerhard Gmel
Apr 25, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jean-François Etter, Nina G Schneider
Apr 15, 2011·BMC Public Health·Pedro Marques-VidalJacques Cornuz
Mar 12, 2013·Environmental Science & Technology·Oleksii MotorykinStaci L Massey Simonich
Jun 19, 2012·Addiction·Jean-François EtterJohn R Hughes
Jul 23, 2013·Internal Medicine Journal·A AlsuwaidaA Alkhalaf
May 17, 2011·Drug and Alcohol Dependence·Jean-François Etter
Jan 17, 2015·Drug and Alcohol Dependence·Jean-François Etter
Aug 20, 2016·Journal of the American College of Cardiology·Jean-François Etter, Felicia Schmid
Dec 17, 2014·Journal of Health Psychology·Erdem Pulcu
Apr 19, 2015·BMC Infectious Diseases·Aparna MukherjeeRakesh Lodha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.